Elsevier, The Lancet Obstetrics, Gynaecology, & Women's Health, Volume 1, Issue 2, October 2025, Pages e122-e131
This is the largest cohort study to date of women with hyperemesis gravidarum, and it is the first to explore a wide array of neuropsychiatric and mental health outcomes, including psychotic disorder. Evidence study suggests that while hyperemesis gravidarum increases the risk of poor mental health compared to unaffected pregnancies, the link between its severity and psychiatric burden is complex. The lower depression risk in cases with metabolic disturbance versus mild disease may reflect varying levels of healthcare support.
Elsevier, The Lancet Obstetrics, Gynaecology, & Women's Health, Volume 1, Issue 2, October 2025, Pages e114-e121
This first large-scale study of the E-MOTIVE intervention in South Asia, conducted across eight Pakistani hospitals with over 14,000 women, showed significant reductions in severe postpartum hemorrhage outcomes and improved adherence to timely bundled treatment.
This article is a review of the global commitments to ending hunger and achieving SDG2 by 2030, analisesthe rhetoric, actionable plans, financing, and accountability mechanisms. Strengthening global governance and institutionalizing monitoring of commitments are essential to translate these declarations into effective national policies.
Elsevier, CMI Communications, Volume 2, Issue 4, December 2025, 105123
This article was released in honor of International Women's Day as a two-part special examining gender dynamics in infectious diseases and clinical microbiology, featuring discussions on gender bias, workplace challenges, and systemic barriers affecting women in medicine. The episodes directly support UN SDG Goal 5 (Gender Equality) by addressing gender equity issues in healthcare professions and exploring solutions to promote more inclusive, supportive environments for all medical professionals regardless of gender.
Elsevier, Journal of Prevention of Alzheimer's Disease, Volume 12, 1 September 2025
The TRAILBLAZER-ALZ 6 study found that a modified donanemab titration regimen significantly reduced ARIA-E frequency and severity compared to standard dosing, while maintaining similar amyloid reduction. Safety profiles were comparable between the two arms. The modified titration approach may help mitigate risks associated with amyloid-targeting therapies in early Alzheimer's disease.
Elsevier, Journal of the Society for Cardiovascular Angiography and Interventions, Volume 4, September 2025
The 30-day Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) has been used to risk-stratify patients undergoing transcatheter aortic valve replacement (TAVR). Whether surgical mortality risk predicts stroke and neurocognitive outcomes following TAVR is unknown. We evaluated the association between STS-PROM and clinical outcomes, including stroke, acute brain injury on diffusion-weighted magnetic resonance imaging (DW-MRI), and cognitive decline in patients undergoing TAVR.
Elsevier, Results in Engineering, Volume 27, September 2025
This study introduces a new, safe, affordable, and non-invasive device designed to detect and monitor early signs of Alzheimer's disease. Unlike traditional tests like MRI or CT scans, this device uses microwaves to examine the brain.
The article discusses the potential of neuron-derived extracellular vesicles (NDEVs) as diagnostic biomarkers for Alzheimer's disease (AD). NDEVs carry pathological proteins like amyloid-? and Tau, and their levels in bodily fluids can distinguish AD patients from healthy controls and predict disease onset.
Elsevier, Cell Reports Sustainability, Volume 2, 26 September 2025
Food waste is an increasing global food security concern. This commentary discusses the drivers behind the growth of food waste with economic growth in particular linked with increasing food waste.
